YBX1 and neoplasm: The knocking down of YBX1 resulted in the suppression of these glycolytic genes, the reduced expression of EMT-related genes, and decreased tumor migration and invasion, highlighting not only the relevance of YBX1-glycolysis-EMT network in TNBC, but also suggesting its potential as a valuable metabolic target in TNBC patients [56].